<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0002714"><a href="http://purl.obolibrary.org/obo/MONDO_0002714">MONDO:0002714</a></h3>
<p><strong>Label:</strong> central nervous system cancer</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0009837">MONDO:0009837</a> (choroid plexus papilloma), <a href="http://purl.obolibrary.org/obo/MONDO_0016642">MONDO:0016642</a> (meningioma (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0016722">MONDO:0016722</a> (pineoblastoma), <a href="http://purl.obolibrary.org/obo/MONDO_0016733">MONDO:0016733</a> (ganglioglioma), <a href="http://purl.obolibrary.org/obo/MONDO_0005499">MONDO:0005499</a> (brain glioma), <a href="http://purl.obolibrary.org/obo/MONDO_0020560">MONDO:0020560</a> (atypical teratoid rhabdoid tumor), <a href="http://purl.obolibrary.org/obo/MONDO_0018177">MONDO:0018177</a> (glioblastoma (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0013093">MONDO:0013093</a> (glioma susceptibility 3), <a href="http://purl.obolibrary.org/obo/MONDO_0017582">MONDO:0017582</a> (pituitary carcinoma (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0007959">MONDO:0007959</a> (medulloblastoma), <a href="http://purl.obolibrary.org/obo/MONDO_0016715">MONDO:0016715</a> (ependymoblastoma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_360">Orphanet:360</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251909">Orphanet:251909</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2807">Orphanet:2807</a>, <a href="http://purl.obolibrary.org/obo/OMIM_155255">OMIM:155255</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251949">Orphanet:251949</a>, <a href="http://purl.obolibrary.org/obo/OMIM_137800">OMIM:137800</a>, <a href="http://www.orpha.net/ORDO/Orphanet_300385">Orphanet:300385</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251858">Orphanet:251858</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251867">Orphanet:251867</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251899">Orphanet:251899</a>, <a href="http://purl.obolibrary.org/obo/OMIM_606190">OMIM:606190</a>, <a href="http://purl.obolibrary.org/obo/OMIM_260500">OMIM:260500</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251863">Orphanet:251863</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2495">Orphanet:2495</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613029">OMIM:613029</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613028">OMIM:613028</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251880">Orphanet:251880</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99966">Orphanet:99966</a>, <a href="http://www.orpha.net/ORDO/Orphanet_616">Orphanet:616</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609322">OMIM:609322</a>, <a href="http://www.orpha.net/ORDO/Orphanet_182067">Orphanet:182067</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001574">HP:0001574</a> (Abnormality of the integument))) 56.55%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000951">HP:0000951</a> (Abnormality of the skin))) 52.02%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000271">HP:0000271</a> (Abnormality of the face))) 49.74%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002315">HP:0002315</a> (Headache) and <a href="http://purl.obolibrary.org/obo/HP_0012443">HP:0012443</a> (Abnormality of brain morphology) and <a href="http://purl.obolibrary.org/obo/HP_0100006">HP:0100006</a> (Neoplasm of the central nervous system) 49.64%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012374">HP:0012374</a> (Abnormality of the globe))) 48.75%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012372">HP:0012372</a> (Abnormal eye morphology))) 48.75%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) and <a href="http://purl.obolibrary.org/obo/HP_0012443">HP:0012443</a> (Abnormality of brain morphology) and <a href="http://purl.obolibrary.org/obo/HP_0100006">HP:0100006</a> (Neoplasm of the central nervous system) 48.25%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100006">HP:0100006</a> (Neoplasm of the central nervous system) 47.78%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002315">HP:0002315</a> (Headache) and <a href="http://purl.obolibrary.org/obo/HP_0100006">HP:0100006</a> (Neoplasm of the central nervous system) 47.02%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system))) 45.91%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012443">HP:0012443</a> (Abnormality of brain morphology) and <a href="http://purl.obolibrary.org/obo/HP_0100006">HP:0100006</a> (Neoplasm of the central nervous system) 45.77%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000315">HP:0000315</a> (Abnormality of the orbital region))) 45.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004375">HP:0004375</a> (Neoplasm of the nervous system) 44.97%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) and <a href="http://purl.obolibrary.org/obo/HP_0100006">HP:0100006</a> (Neoplasm of the central nervous system) 44.90%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002118">HP:0002118</a> (Abnormality of the cerebral ventricles) and <a href="http://purl.obolibrary.org/obo/HP_0100006">HP:0100006</a> (Neoplasm of the central nervous system) 43.99%</li>
</ul>
</body>
</html>
